• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

利用氟代脱氧葡萄糖正电子发射断层扫描(FDG-PET)对肝细胞癌葡萄糖代谢进行体内评估。

In vivo assessment of glucose metabolism in hepatocellular carcinoma with FDG-PET.

作者信息

Torizuka T, Tamaki N, Inokuma T, Magata Y, Sasayama S, Yonekura Y, Tanaka A, Yamaoka Y, Yamamoto K, Konishi J

机构信息

Department of Nuclear Medicine, Kyoto University Faculty of Medicine, Japan.

出版信息

J Nucl Med. 1995 Oct;36(10):1811-7.

PMID:7562048
Abstract

UNLABELLED

The present study was designed to assess glucose metabolism in hepatocellular carcinoma (HCC) with PET and [18F]fluorodeoxyglucose (FDG) and to compare the results with the measured in vitro enzymatic activity of glucose metabolism and the histologic grading of HCC.

METHODS

Dynamic FDG-PET scans were obtained in 17 preoperative patients with HCC. From the serial tissue and arterial radioactivities obtained by dynamic PET, FDG kinetic rate constants (K1 to k4) were obtained. The standardized uptake value (SUV) was also determined from the images acquired 48 to 60 min after FDG administration. These PET results were compared with hexokinase and glucose-6-phosphatase (G6Pase) activities and histologic grading of HCC in surgically resected tumor materials. According to histologic grading, the tumors were divided into low-grade and high-grade HCCs.

RESULTS

The k3 and SUV of high-grade HCCs were significantly higher than those of low-grade HCCs (p < 0.005, each). In addition, high correlations were observed between the hexokinase activities and these two parameters (r = 0.715 0.768, respectively). In some HCCs, relatively high G6Pase activities and k4 values modified tumor FDG uptake.

CONCLUSION

FDG PET is a valuable method for assessing glucose metabolism and histologic grading of HCC.

摘要

未标注

本研究旨在通过正电子发射断层扫描(PET)和[18F]氟脱氧葡萄糖(FDG)评估肝细胞癌(HCC)中的葡萄糖代谢,并将结果与体外测量的葡萄糖代谢酶活性及HCC的组织学分级进行比较。

方法

对17例术前HCC患者进行动态FDG-PET扫描。从动态PET获得的系列组织和动脉放射性中,得出FDG动力学速率常数(K1至k4)。还从FDG给药后48至60分钟采集的图像中确定标准化摄取值(SUV)。将这些PET结果与手术切除肿瘤材料中HCC的己糖激酶和葡萄糖-6-磷酸酶(G6Pase)活性及组织学分级进行比较。根据组织学分级,将肿瘤分为低级别和高级别HCC。

结果

高级别HCC的k3和SUV显著高于低级别HCC(均为p < 0.005)。此外,己糖激酶活性与这两个参数之间存在高度相关性(分别为r = 0.715和0.768)。在一些HCC中,相对较高的G6Pase活性和k4值改变了肿瘤的FDG摄取。

结论

FDG PET是评估HCC葡萄糖代谢和组织学分级的有价值方法。

相似文献

1
In vivo assessment of glucose metabolism in hepatocellular carcinoma with FDG-PET.利用氟代脱氧葡萄糖正电子发射断层扫描(FDG-PET)对肝细胞癌葡萄糖代谢进行体内评估。
J Nucl Med. 1995 Oct;36(10):1811-7.
2
[Can fluorodeoxyglucose-positron emission tomography evaluate the functional differentiation of hepatocellular carcinoma].
Kaku Igaku. 1991 Nov;28(11):1353-6.
3
Evaluation of liver tumors using fluorine-18-fluorodeoxyglucose PET: characterization of tumor and assessment of effect of treatment.
J Nucl Med. 1992 Mar;33(3):333-9.
4
Value of fluorine-18-FDG-PET to monitor hepatocellular carcinoma after interventional therapy.
J Nucl Med. 1994 Dec;35(12):1965-9.
5
P-glycoprotein expression affects 18F-fluorodeoxyglucose accumulation in hepatocellular carcinoma in vivo and in vitro.P-糖蛋白表达在体内和体外均影响18F-氟脱氧葡萄糖在肝细胞癌中的积聚。
Int J Oncol. 2009 May;34(5):1303-12.
6
Molecular mechanisms of [18F]fluorodeoxyglucose accumulation in liver cancer.肝癌中[18F]氟脱氧葡萄糖积聚的分子机制。
Oncol Rep. 2014 Feb;31(2):701-6. doi: 10.3892/or.2013.2886. Epub 2013 Nov 29.
7
Role of FDG-PET in the evaluation and staging of hepatocellular carcinoma with comparison of tumor size, AFP level, and histologic grade.18F-氟代脱氧葡萄糖正电子发射断层扫描(FDG-PET)在肝细胞癌评估及分期中的作用,并与肿瘤大小、甲胎蛋白水平及组织学分级进行比较
Int Surg. 2010 Jan-Mar;95(1):67-75.
8
Fluorine-18 FDG positron emission tomography for imaging of hepatocellular carcinoma.用于肝细胞癌成像的氟-18 FDG正电子发射断层扫描
Am J Gastroenterol. 1999 Nov;94(11):3314-9. doi: 10.1111/j.1572-0241.1999.01544.x.
9
Evaluation of metabolic characteristics and viability of lipiodolized hepatocellular carcinomas using 18F-FDG PET/CT.使用 18F-FDG PET/CT 评估碘油化疗栓塞肝癌的代谢特征和活力。
J Nucl Med. 2010 Dec;51(12):1849-56. doi: 10.2967/jnumed.110.079244.
10
The role of [18F]fluorodeoxyglucose positron emission tomography imaging in the evaluation of hepatocellular carcinoma.[18F]氟脱氧葡萄糖正电子发射断层扫描成像在肝细胞癌评估中的作用
Am Surg. 2003 Feb;69(2):117-24; discussion 124-6.

引用本文的文献

1
PET imaging of hepatocellular carcinoma with [I]IV-14.使用[I]IV-14对肝细胞癌进行正电子发射断层显像(PET)成像。
EJNMMI Res. 2025 Apr 7;15(1):35. doi: 10.1186/s13550-025-01227-5.
2
Glucosamine Inhibits the Proliferation of Hepatocellular Carcinoma Cells by Eliciting Apoptosis, Autophagy, and the Anti-Warburg Effect.氨基葡萄糖通过引发细胞凋亡、自噬和抗瓦伯格效应来抑制肝癌细胞的增殖。
Scientifica (Cairo). 2025 Jan 8;2025:5685884. doi: 10.1155/sci5/5685884. eCollection 2025.
3
F-FAPI-42 PET/CT and F-FDG PET/CT in Patients with Malignant Digestive System Neoplasms: A Head-to-Head Comparative Study.
F-FAPI-42 PET/CT与F-FDG PET/CT在恶性消化系统肿瘤患者中的应用:一项直接对比研究
Mol Imaging Biol. 2025 Feb;27(1):131-141. doi: 10.1007/s11307-025-01982-w. Epub 2025 Jan 13.
4
Estimation of liver standardized uptake value in F18-FDG PET/CT scanning: impact of different malignancies, blood glucose level, body weight normalization, and imaging systems.F18-FDG PET/CT扫描中肝脏标准化摄取值的估计:不同恶性肿瘤、血糖水平、体重标准化及成像系统的影响
Ann Nucl Med. 2025 Feb;39(2):176-188. doi: 10.1007/s12149-024-01985-7. Epub 2024 Oct 16.
5
Increased [F]FDG uptake of radiation-induced giant cells: a single-cell study in lung cancer models.辐射诱导的巨细胞中[F]FDG摄取增加:肺癌模型中的单细胞研究
Npj Imaging. 2024;2(1):14. doi: 10.1038/s44303-024-00017-3. Epub 2024 Jun 19.
6
Generation of Whole-Body FDG Parametric Images from Static PET Images Using Deep Learning.利用深度学习从静态PET图像生成全身FDG参数图像
IEEE Trans Radiat Plasma Med Sci. 2023 May;7(5):465-472. doi: 10.1109/trpms.2023.3243576. Epub 2023 Feb 22.
7
Modulation of FDG Uptake by Cell Cycle Synchronization Using a T-Type Calcium Channel Inhibitor.使用T型钙通道抑制剂通过细胞周期同步化调节氟代脱氧葡萄糖摄取
Cancers (Basel). 2023 Oct 31;15(21):5244. doi: 10.3390/cancers15215244.
8
Achievement of Complete Response and Drug-Free Status by Atezolizumab plus Bevacizumab Combined with or without Curative Conversion in Patients with Transarterial Chemoembolization-Unsuitable, Intermediate-Stage Hepatocellular Carcinoma: A Multicenter Proof-Of-Concept Study.阿替利珠单抗联合贝伐单抗加或不加根治性转化治疗经动脉化疗栓塞不适合的中期肝细胞癌患者实现完全缓解和无药状态:一项多中心概念验证研究
Liver Cancer. 2023 Feb 7;12(4):321-338. doi: 10.1159/000529574. eCollection 2023 Sep.
9
Assessing dynamic metabolic heterogeneity in prostate cancer patients via total-body [Ga]Ga-PSMA-11 PET/CT imaging: quantitative analysis of [Ga]Ga-PSMA-11 uptake in pathological lesions and normal organs.通过全身[Ga]Ga-PSMA-11 PET/CT 成像评估前列腺癌患者的动态代谢异质性:病理性病变和正常器官中[Ga]Ga-PSMA-11 摄取的定量分析。
Eur J Nucl Med Mol Imaging. 2024 Feb;51(3):896-906. doi: 10.1007/s00259-023-06475-y. Epub 2023 Oct 27.
10
The application of F-FDG PET/CT imaging for human hepatocellular carcinoma: a narrative review.18F-氟脱氧葡萄糖正电子发射断层扫描/计算机断层扫描成像在人类肝细胞癌中的应用:一项叙述性综述。
Quant Imaging Med Surg. 2023 Sep 1;13(9):6268-6279. doi: 10.21037/qims-22-1420. Epub 2023 Aug 4.